永升(01995.HK)急涨近17%突破50天线 全年盈利及末期息倍增获野村升价至8.4元
永升生活服务(01995.HK)全年盈利及末期股息均倍增,野村绩後重申永升「买入」评级及上调目标价10%至8.4元,以反映公司全年盈利及营收均超预期兼估值持续被低估。该股今早急一举重越10天、50天及20天线(7.06-7.53元),最高见7.84元,现造7.82元,急弹近17%,成交增至1,210万股,涉资8,910万元。
永升公布,截至去年底止全年纯利急增逾1.2倍至2.24亿元人民币(下同),每股盈利14.58分,末期股息按年增近1.1倍至4.79港仙。期内,总收入按年增74.5%至18.78亿元;毛利按年升约80%至5.55亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.